Related Experiment Video
Updated: May 26, 2026

In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
Intrathecal opioid conversions: the importance of lipophilicity
M A Royal1, D L Wiesemeyer, V Gordin
1Oklahoma University School of Medicine, Pain Evaluation & Treatment Center, Tulsa, OK 74135.
Abstract:
An intrathecal opioid infusion using an implanted programmable pump is frequently used for controlling refractory pain. Morphine, which is the only opioid presently approved by the FDA for use in such pumps, occasionally fails to work or is not tolerated by the patient; therefore other opioids are considered for infusions. When switching from one drug to another, it is important to consider not only equianalgesic dose conversions, but also lipophilicity. We report on three cases that demonstrate the need to use only a fraction of the equianalgesic dose when shifting from lipophilic to nonlipophilic opioids in such infusions.
More Related Videos
Related Concept Videos
IV Infusion to Oral Dosing: Conversion Methods
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Biotransformation: Overview
Opioid Receptors: Overview

